XML 57 R41.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation (Tables)
12 Months Ended
Apr. 24, 2021
Share-based Payment Arrangement [Abstract]  
Summary of Total Stock-Based Compensation Expense
The table below summarizes the total stock-based compensation expense recognized for all outstanding grants in our consolidated statement of income:
Fiscal Year Ended
(52 weeks)(52 weeks)(52 weeks)
(Amounts in thousands)4/24/20214/25/20204/27/2019
Equity-based awards expense
Stock options $2,959 $2,000 $3,507 
Restricted stock awards3,367 2,913 2,548 
Restricted stock units issued to Directors840 900 704 
Performance-based shares5,505 2,558 4,222 
Total equity-based awards expense12,671 8,371 10,981 
Liability-based awards expense
Stock appreciation rights375 (240)98 
Restricted stock units 43 20 22 
Performance-based units23 
Deferred stock units1,437 (768)212 
Total liability-based awards expense1,878 (982)339 
Total stock-based compensation expense (1)
$14,549 $7,389 $11,320 
(1)Stock-based compensation expense is recorded in SG&A expense in the consolidated statement of income.
Schedule of Plan Activity for Stock Options
Plan activity for stock options under the above plans was as follows:
Number of Shares
(In Thousands)
Weighted Average Exercise Price
Weighted Average Remaining Contractual Term
 (Years)
Aggregate Intrinsic Value
(In Thousands)
Outstanding at April 25, 20201,438 $28.76 7.2$103 
Granted316 27.54 N/AN/A
Canceled(7)31.34 N/AN/A
Exercised(405)26.79 N/A5,102 
Outstanding at April 24, 20211,342 29.05 7.219,008 
Exercisable at April 24, 2021592 $28.67 6.0$8,609 
Fair Value Assumptions for Stock Options The fair value of stock options granted during fiscal 2021, fiscal 2020, and fiscal 2019 were calculated using the following assumptions:
Fiscal 2021 grantFiscal 2020 grantFiscal 2019 grant
Risk-free interest rate0.34 %2.19 %2.82 %
Dividend rate— %1.72 %1.45 %
Expected life in years5.05.05.0
Stock price volatility41.79 %34.27 %33.07 %
Fair value per share$10.06 $7.94 $9.65 
Summary of Information about Non-Vested Share Awards
The following table summarizes information about non-vested share awards as of and for the year ended April 24, 2021:
 
Shares
(In Thousands)
Weighted Average Grant Date Fair Value
Non-vested shares at April 25, 2020293 $30.34 
Granted138 29.35 
Vested(102)29.66 
Canceled(9)30.20 
Non-vested shares at April 24, 2021320 30.14 
Summary of Information about Performance-Based Shares Outstanding
The following table summarizes the performance-based shares outstanding at the maximum award amounts based upon the respective performance share agreements:
 
Shares
(In Thousands)
Weighted Average Grant Date Fair Value
Outstanding shares at April 25, 2020534 $29.21 
Granted337 30.75 
Vested(98)25.93 
Unearned or canceled(104)30.30 
Outstanding shares at April 24, 2021669 30.32 
Schedule of Equity-Based Compensation Expenses Related to Performance-Based Shares
Equity-based compensation expenses related to performance-based shares recognized in our consolidated statement of income were as follows (for the fiscal years ended):
Fiscal Year Ended
(52 weeks)(52 weeks)(52 weeks)
(Amounts in thousands)4/24/20214/25/20204/27/2019
Fiscal 2017 grant$— $— $1,044 
Fiscal 2018 grant— 611 1,402 
Fiscal 2019 grant1,545 996 1,776 
Fiscal 2020 grant2,051 951 — 
Fiscal 2021 grant1,909 — — 
Total expense$5,505 $2,558 $4,222